Advertisement

 

 

Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish Regions.

Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish Regions.
Author Information (click to view)

Salvador J, Urtasun JA, Duart FJ, García-Campelo R, Carbonero RG, Lianes P, Llombart A, Casado DI, Piera JM, Mateu MM, Puente J, Rivera F, Rodríguez CA, Virizuela JA, Martín M, Garrido P,


Salvador J, Urtasun JA, Duart FJ, García-Campelo R, Carbonero RG, Lianes P, Llombart A, Casado DI, Piera JM, Mateu MM, Puente J, Rivera F, Rodríguez CA, Virizuela JA, Martín M, Garrido P, (click to view)

Salvador J, Urtasun JA, Duart FJ, García-Campelo R, Carbonero RG, Lianes P, Llombart A, Casado DI, Piera JM, Mateu MM, Puente J, Rivera F, Rodríguez CA, Virizuela JA, Martín M, Garrido P,

Advertisement

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2016 08 2519(3) 341-356 doi 10.1007/s12094-016-1535-8
Abstract
PURPOSE
The Spanish Society of Medical Oncology (SEOM) has conducted a study on the access to oncologic drugs across the 17 Spanish Regions with the aim of identifying potential heterogeneities and making proposals for eliminating the barriers identified at the different levels.

METHODS
An Expert Panel made up of medical oncologists designed a survey on certain indications approved for 11 drugs in the approach of breast cancer, melanoma, lung cancer, prostate cancer and support treatment. This survey was sent to 144 National Health System (NHS) hospitals.

RESULTS
77 hospitals answered the survey. The information modules analysed were: scope of the Commission that establishes binding decisions related to drug access; conditions, stages and periods of drug application, approval and administration processes; barriers to accessing drugs.

CONCLUSIONS
The study shows variability in drug access. The SEOM makes proposals addressed to reducing the differences identified and homogenizing drug access conditions.

Submit a Comment

Your email address will not be published. Required fields are marked *

2 × five =

[ HIDE/SHOW ]